Sign in
4

Changes in Ownership

Invivyd, Inc. Filed Acc 0000950170-25-110339

Chief Scientific Officer sold 45,932 shares at an average $0.60 ($27,573)

  • Chief Scientific Officer acquired 99,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Allen Robert D. III · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-15 Exercise or conversion : show line 1 in the form 10b5-1 +99,000 99,000 D
2025-08-18 Sale : show line 2 in the form 10b5-1 −18,512 $0.65 $12,037 80,488 D
2025-08-19 Sale : show line 3 in the form 10b5-1 −27,420 $0.57 $15,536 53,068 D
Open-market sales · 45,932 sh · avg $0.60 · $27,573

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-15 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units −99,000 201,000 D
Loading xslF345X05/ownership.xml…